Financial Capital

Numbers testifying our growth Potential

At Metropolis, our financial capital testifies for our view and prudence in ensuring optimal resource allocation and control systems to drive the business’ operations. Our strategic investments further strengthen our business’ growth momentum overall performance. The following is a snapshot of the Company’s Revenue, EBITDA, PAT along with Revenue per Test and Revenue per customer, as recorded during the year under review.

EBITDA: Earnings before interest, tax, depreciation, and amortization PAT: Profit after Tax excluding exceptional items *In FY 20-21, Revenue per Patient & Test is high due to high revenue per test of Covid in first 6 months